Trending Now
Tivic Health Systems Inc. (NASDAQ: TIVC): A Promising Leap with New...
Tivic Health® Systems, Inc. (NASDAQ: TIVC), a pioneering health tech company in bioelectronic medicine, recently announced significant advancements with the grant of...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) Expands Its Intellectual Property Associated With Mino-Wrap...
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) is pursuing a new standard of care thanks to the growing markets and demand for advanced cancer drugs. The company...
MAKE IT MODERN
LATEST REVIEWS
Most Active Penny Stocks To Watch (BTE, MTC, WHEN, MDAI, MGUY)
The realm of penny stocks, commonly defined as stocks priced under $5 per share, has long captivated traders and investors due to...
MAKE IT MODERN
PERFORMANCE TRAINING
Novabay Pharmaceuticals Inc. (NYSEAMERICAN:NBY) Enters Agreement For Distribution Of Avenova In Australia
Novabay Pharmaceuticals Inc. (NYSEAMERICAN:NBY) has entered an exclusive agreement with Paragon Care Group Australia Pty Ltd for the distribution of Avenova in Australia. According...
VIX finally shows signs of stabilization
Markets got a little pop today, but nothing extraordinary. We are finally seeing the VIX come off its highs. However, the VVIX...
What Lies Ahead for the $150B Ad Industry (CMGR, ROKU, VIAC, PINS, SNAP, TTD)
There’s $150 billion in annual spending that has become homeless. It now wanders around the global economy, aimless, lost, searching for a...
ISWH Heats Up as New Bitcoin Play
Bitcoin is rampaging higher, but it doesn’t come as much of a surprise to insiders in the space who have been looking...
Akero Therapeutics Inc. (NASDAQ: AKRO) Completes Enrolment in Phase 2b HARMONY Study Of Efrixifermin...
Akero Therapeutics Inc. (NASDAQ: AKRO) has announced the completion of enrolment in the Phase 2b HARMONY trial of its novel FGF21, Efruxifermin (EFX) for...
MAKE IT MODERN
